Duloxetine for the long-term treatment of Major Depressive Disorder in patients aged 65 and older: an open-label study

BACKGROUND: Late-life depression is a common, chronic and recurring disorder for which guidelines recommend long-term therapy. The safety and efficacy of duloxetine for the treatment of major depressive disorder (MDD) were evaluated using data from elderly patients (age ≥ 65 years; n = 101) who part...

Descripción completa

Detalles Bibliográficos
Autores principales: Wohlreich, Madelaine M, Mallinckrodt, Craig H, Watkin, John G, Hay, Donald P
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2004
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC544561/
https://www.ncbi.nlm.nih.gov/pubmed/15585058
http://dx.doi.org/10.1186/1471-2318-4-11

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC544561/
https://www.ncbi.nlm.nih.gov/pubmed/15585058
http://dx.doi.org/10.1186/1471-2318-4-11

Ejemplares similares